Skip to main content
Erschienen in: Reactions Weekly 1/2023

01.10.2023 | Case report

Cetuximab-sarotalocan

Infusion related reaction: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Omura G, et al. Transnasal photoimmunotherapy with cetuximab sarotalocan sodium: Outcomes on the local recurrence of nasopharyngeal squamous cell carcinoma. Auris Nasus Larynx 50 : 641-645, No. 4, Aug 2023. Available from: URL: www.elsevier.com/inca/publications/store/6/0/0/1/0/4 Omura G, et al. Transnasal photoimmunotherapy with cetuximab sarotalocan sodium: Outcomes on the local recurrence of nasopharyngeal squamous cell carcinoma. Auris Nasus Larynx 50 : 641-645, No. 4, Aug 2023. Available from: URL: www.elsevier.com/inca/publications/store/6/0/0/1/0/4
Metadaten
Titel
Cetuximab-sarotalocan
Infusion related reaction: case report
Publikationsdatum
01.10.2023
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-023-47169-6

Weitere Artikel der Ausgabe 1/2023

Reactions Weekly 1/2023 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Fosravuconazole